Inovio Pharma (INO) Misses Q3 EPS by 2c

November 9, 2016 7:14 AM EST

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.54 million versus the consensus estimate of $5.16 million.

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment